Skip to main content

PureVax Feline 3/Rabies (Canada)

This page contains information on PureVax Feline 3/Rabies for veterinary use.
The information provided typically includes the following:
  • PureVax Feline 3/Rabies Indications
  • Warnings and cautions for PureVax Feline 3/Rabies
  • Direction and dosage information for PureVax Feline 3/Rabies

PureVax Feline 3/Rabies

This treatment applies to the following species:
Company: Merial

Feline Rhinotracheitis-Calici-Panleukopenia-Rabies Vaccine

Modified Live Virus, Canarypox Vector

(RCP/rRabies-SWD)

DESCRIPTION: PUREVAX® Feline 3/Rabies contains a nonadjuvanted lyophilized suspension of modified live feline rhinotracheitis, calici, and panleukopenia viruses; recombinant vectored rabies vaccine; plus a sterile water diluent. A canarypox vector has been modified, using recombinant technology, to produce expression of desired antigens capable of stimulating a protective immune response to rabies. Safety and immunogenicity of this product have been demonstrated by vaccination and challenge studies in susceptible cats.

INDICATIONS: PUREVAX® Feline 3/Rabies is recommended for the vaccination of healthy cats 8 weeks of age or older for prevention of disease due to feline rhinotracheitis, calici, panleukopenia, and rabies viruses.

DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject 1 mL (1 dose) subcutaneously into healthy cats. For primary vaccination of cats younger than 12 weeks of age, revaccinate every 3 to 4 weeks with the last dose given at or over 12 weeks of age. For primary vaccination of cats 12 weeks or older, revaccinate with a second 1 ml dose of this product or Code 16D8.21 (Purevax® Feline 3), 3 to 4 weeks later. Revaccinate annually with a single 1 mL dose.

PRECAUTIONS: Store at 2-7°C (35-45°F). Use immediately after reconstitution. Do not use chemicals to sterilize syringes and needles. Burn this container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate pregnant cats. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine.

SOLD TO VETERINARIANS ONLY.

Store at 2-7°C (35-45°F).

For Veterinary Use Only.

PUREVAX is a registered trademark of MERIAL.

Manufactured By MERIAL INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, (Québec), H9X 4B6, Canada

Contains

 

Prod. No.

 

25 Doses

25 x 1 Dose, Lyophilized

25 x 1 mL, Sterile Water

2132-25

RM820R6

CPN: 11820513

BOEHRINGER INGELHEIM ANIMAL HEALTH CANADA INC.
5180 SOUTH SERVICE ROAD, BURLINGTON, ON, L7L 5H4
Customer Care No.:   1-800-567-1885
Technical Services No.:   1-877-565-5501
Website:   www.boehringer-ingelheim.ca
THIS SERVICE AND DATA ARE PROVIDED "AS IS". Animalytix assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the Animalytix service and data. See the Terms of Use for further details.

Copyright © 2023 Animalytix LLC. Updated: 2023-02-28